PM

#46
Philip Morris International Inc Common Stock
177.4 1 USD
-0.68%
Sector: Valores de Consumo Defensivo
Básica: USD
Divisa de beneficio: USD
Rango diario
177.17
178.09
Rango anual
142.11
193.05
Cambio diario
-0.68%
Variación mensual
+8.55%
Variación en los últimos 6 meses
+12.86%
Cambio anual
-0.34%
Cierres anteriores
178.6 2
Open
177.6 1
Mínimo
177.1 7
High
178.0 9
Volumen
1 718
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 276.5 B
  • Employee 85 K
  • Founded N/A
  • CEO Jacek Olczak
  • Website www.pmi.com
  • Headquarter Virginia, United States
  • FIGI BBG000J2XL74
  • Industry Productos del tabaco
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
23.29
Relación precio/flujo de caja
6.21
Dividendos por acción
1.47
Rendimiento por dividendo, %
6.01

Philip Morris International Inc Common Stock

Philip Morris International Inc. is a tobacco company, with products sold in over 180 countries. Marlboro is PMI’s most recognized brand, but in the last quarter of 2023, Iqos generated the greatest revenue. Philip Morris International is often referred to as one of the companies comprising Big Tobacco. The company ranked No. 121 in the 2025 Fortune 500 list of the largest US corporations by total revenue. The company originated in 1847 in London, but Philip Morris International itself was established in 1987 as an operating company of Philip Morris Companies Inc. In 2003, Philip Morris Companies changed its name to Altria Group. In March 2008, PMI was spun off from Altria and has been an entirely separate entity since then. Philip Morris USA, a subsidiary of PMI's former parent, keeps ownership of the Philip Morris brands for the US market. The company's legal seat is in Stamford, Connecticut. PMI's operational headquarters are in Lausanne, Switzerland. With tobacco being addictive and a leading cause of preventable death globally, the company has faced litigation and regulatory measures from governments and has been the subject of scrutiny by the World Health Organization.

Noticias